Morrow M - Search Results

1

Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.

Reiner AS, Lynch CF, Sisti JS, John EM, Brooks JD, Bernstein L, Knight JA, Hsu L, Concannon P, Mellemkjær L, Tischkowitz M, Haile RW, Shen R, Malone KE, Woods M, Liang X, Morrow M, Bernstein JL; WECARE Study Collaborative Group. Reiner AS, et al. Among authors: morrow m. Breast Cancer Res. 2017 Jul 19;19(1):83. doi: 10.1186/s13058-017-0874-x. Breast Cancer Res. 2017. PMID: 28724391 Free PMC article.

2

Presenting features of breast cancer differ by molecular subtype.

Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, Morrow M. Wiechmann L, et al. Among authors: morrow m. Ann Surg Oncol. 2009 Oct;16(10):2705-10. doi: 10.1245/s10434-009-0606-2. Epub 2009 Jul 11. Ann Surg Oncol. 2009. PMID: 19593632

3

Randomized clinical trials in breast cancer.

Crago AM, Azu M, Tierney S, Morrow M. Crago AM, et al. Among authors: morrow m. Surg Oncol Clin N Am. 2010 Jan;19(1):33-58. doi: 10.1016/j.soc.2009.09.003. Surg Oncol Clin N Am. 2010. PMID: 19914559 Review.

4

Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter?

Neuman HB, Morrogh M, Gonen M, Van Zee KJ, Morrow M, King TA. Neuman HB, et al. Among authors: morrow m. Cancer. 2010 Mar 1;116(5):1226-33. doi: 10.1002/cncr.24873. Cancer. 2010. PMID: 20101736 Free PMC article.

5

Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?

Port ER, Patil S, Stempel M, Morrow M, Cody HS 3rd. Port ER, et al. Among authors: morrow m. Cancer. 2010 Apr 15;116(8):1987-91. doi: 10.1002/cncr.24964. Cancer. 2010. PMID: 20151427 Free article.

6

History of smoking is associated with younger age at diagnosis of breast cancer.

Abramowitz MC, Li T, Morrow M, Anderson PR, Bleicher RJ, Goldstein LJ, Swaby R, Nicoloau N, Freedman GM. Abramowitz MC, et al. Among authors: morrow m. Breast J. 2010 Jul-Aug;16(4):344-9. doi: 10.1111/j.1524-4741.2010.00921.x. Epub 2010 Apr 21. Breast J. 2010. PMID: 20443785

7

A prospective evaluation of the durability of palliative interventions for patients with metastatic breast cancer.

Morrogh M, Miner TJ, Park A, Jenckes A, Gonen M, Seidman A, Morrow M, Jaques DP, King TA. Morrogh M, et al. Among authors: morrow m. Cancer. 2010 Jul 15;116(14):3338-47. doi: 10.1002/cncr.25034. Cancer. 2010. PMID: 20564060 Free PMC article.

8

Impact of breast density on the presenting features of malignancy.

Arora N, King TA, Jacks LM, Stempel MM, Patil S, Morris E, Morrow M. Arora N, et al. Among authors: morrow m. Ann Surg Oncol. 2010 Oct;17 Suppl 3:211-8. doi: 10.1245/s10434-010-1237-3. Epub 2010 Sep 19. Ann Surg Oncol. 2010. PMID: 20853035

9

Occult malignancy in patients undergoing contralateral prophylactic mastectomy.

King TA, Gurevich I, Sakr R, Patil S, Stempel M, Morrow M. King TA, et al. Among authors: morrow m. Ann Surg. 2011 Jul;254(1):2-7. doi: 10.1097/SLA.0b013e3182125b26. Ann Surg. 2011. PMID: 21372684

10

Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.

King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, Morrow M. King TA, et al. Among authors: morrow m. J Clin Oncol. 2011 Jun 1;29(16):2158-64. doi: 10.1200/JCO.2010.29.4041. Epub 2011 Apr 4. J Clin Oncol. 2011. PMID: 21464413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,238 results

Search Page